BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23830978)

  • 1. Hypoxia/hepatoma dual specific suicide gene expression plasmid delivery using bio-reducible polymer for hepatocellular carcinoma therapy.
    Kim HA; Nam K; Lee M; Kim SW
    J Control Release; 2013 Oct; 171(1):1-10. PubMed ID: 23830978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
    Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
    Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of hypoxia and glioma dual-specific suicide gene using dexamethasone conjugated polyethylenimine for glioblastoma-specific gene therapy.
    Kim HA; Park JH; Yi N; Lee M
    Mol Pharm; 2014 Mar; 11(3):938-50. PubMed ID: 24467192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypoxia responsive element regulated herpes simplex virus-thymidine kinase system enhances killing effect of gancyclovir on Ewing's sarcoma cell line under hypoxic condition].
    Si YJ; Guang LX; Yuan FH; Zhang KB
    Zhonghua Er Ke Za Zhi; 2006 Aug; 44(8):616-20. PubMed ID: 17083794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HSVtk/GCV system on hepatoma carcinoma cells: Construction of the plasmid pcDNA3.1‑pAFP-TK and targeted killing effect.
    Li YF; Yuan YY; Zhang YM; Zhao N; Zhang Q; Meng FX; Gao RP; Yu BF; Zhang YH; Guo R; Wang HL; Xie J; Xu J; Qin Q; Dong XS
    Mol Med Rep; 2017 Jul; 16(1):764-772. PubMed ID: 28560395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilizing alpha-fetoprotein expression to enhance oncolytic viral therapy in hepatocellular carcinoma.
    Pin RH; Reinblatt M; Fong Y
    Ann Surg; 2004 Oct; 240(4):659-65; discussion 665-6. PubMed ID: 15383793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
    Ido A; Nakata K; Kato Y; Nakao K; Murata K; Fujita M; Ishii N; Tamaoki T; Shiku H; Nagataki S
    Cancer Res; 1995 Jul; 55(14):3105-9. PubMed ID: 7541712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
    Mawatari F; Tsuruta S; Ido A; Ueki T; Nakao K; Kato Y; Tamaoki T; Ishii N; Nakata K
    Cancer Gene Ther; 1998; 5(5):301-6. PubMed ID: 9824049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible gene expression system using the erythropoietin enhancer and 3'-untranslated region for the VEGF gene therapy.
    Lee M; Choi D; Choi MJ; Jeong JH; Kim WJ; Oh S; Kim YH; Bull DA; Kim SW
    J Control Release; 2006 Sep; 115(1):113-9. PubMed ID: 16962197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
    Kanai F; Shiratori Y; Yoshida Y; Wakimoto H; Hamada H; Kanegae Y; Saito I; Nakabayashi H; Tamaoki T; Tanaka T; Lan KH; Kato N; Shiina S; Omata M
    Hepatology; 1996 Jun; 23(6):1359-68. PubMed ID: 8675152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective killing of AFP-positive hepatocellular carcinoma cells by adeno-associated virus transfer of the herpes simplex virus thymidine kinase gene.
    Su H; Chang JC; Xu SM; Kan YW
    Hum Gene Ther; 1996 Mar; 7(4):463-70. PubMed ID: 8800740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for hepatocellular carcinoma based on tumour-selective suicide gene expression using the alpha-fetoprotein (AFP) enhancer and a housekeeping gene promoter.
    Cao G; Kuriyama S; Gao J; Nakatani T; Chen Q; Yoshiji H; Zhao L; Kojima H; Dong Y; Fukui H; Hou J
    Eur J Cancer; 2001 Jan; 37(1):140-7. PubMed ID: 11165141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suicide gene therapy for hepatocellular carcinoma cells by survivin promoter-driven expression of the herpes simplex virus thymidine kinase gene.
    Qu L; Wang Y; Gong L; Zhu J; Gong R; Si J
    Oncol Rep; 2013 Apr; 29(4):1435-40. PubMed ID: 23354806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of the suicide gene driven by the promoter of vascular endothelial growth factor gene against hypoxic tumor cells.
    Koshikawa N; Takenaga K; Tagawa M; Sakiyama S
    Cancer Res; 2000 Jun; 60(11):2936-41. PubMed ID: 10850440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter.
    Tomizawa M; Yu L; Wada A; Tamaoki T; Kadomatsu K; Muramatsu T; Matsubara S; Watanabe K; Ebara M; Saisho H; Sakiyama S; Tagawa M
    Br J Cancer; 2003 Sep; 89(6):1086-90. PubMed ID: 12966430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation.
    Kawashita Y; Ohtsuru A; Kaneda Y; Nagayama Y; Kawazoe Y; Eguchi S; Kuroda H; Fujioka H; Ito M; Kanematsu T; Yamashita S
    Hum Gene Ther; 1999 Jun; 10(9):1509-19. PubMed ID: 10395376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of PEI-Mn0.5Zn0.5Fe2O4 nanoparticles and pHsp 70-HSV-TK/GCV with magnet-induced heating for treatment of hepatoma.
    Tang Q; Lu M; Chen D; Liu P
    Int J Nanomedicine; 2015; 10():7129-43. PubMed ID: 26604760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
    Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C
    Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HSV-TK gene therapy of lung adenocarcinoma xenografts using a hypoxia/radiation dual-sensitive promoter].
    Wang WD; Chen ZT; Li DZ; Duan YZ; Wang ZX; Cao ZH
    Ai Zheng; 2004 Jul; 23(7):788-93. PubMed ID: 15248913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recombinant plasmid pEGFP-AFP-TK delivered by nano-magnetic fluids targeting killed AFP positive HepG2 cells in vitro].
    Luo Y; Zhang YD; Peng J; Yan HX; Xue D; Wu K; Zhou L; Hang SW; Zhao JF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 May; 25(5):437-9. PubMed ID: 19426602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.